AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8695002 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated sensitive teeth)
Number of subjects: 19
Study 2777580 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1 gram)
Number of subjects: 19
Study 2777580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 878122 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection via perineal urethrostomy (Group B)
Number of subjects: 173
Study 878122 — intervention group
Group type: COMPARATOR
Intervention: Resection via the entire urethra (Group C)
Number of subjects: 173
Study 31289439 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipping education program
Number of subjects: 60
Study 31289439 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient education
Number of subjects: 60
Study 28167237 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (4000IU/d) vitamin D3
Number of subjects: 82
Study 28167237 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (4000IU/d) vitamin D3 among those with insufficient 25(OH)D (<75nmol/L) at baseline
Number of subjects: 82
Study 25714615 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg alternate days, 12 weeks)
Number of subjects: 46
Study 25714615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 25714615 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 46
Study 23505005 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual pattern separation in older adults
Number of subjects: 2
Study 23505005 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual pattern separation in older adults
Number of subjects: 2
Study 23505005 — intervention group
Group type: COMPARATOR
Intervention: Perceptual pattern separation in young adults
Number of subjects: 2
Study 23505005 — intervention group
Group type: COMPARATOR
Intervention: Working memory, attention, or visual processing
Number of subjects: 2
Study 21685641 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy (VRET)
Number of subjects: 0
Study 21685641 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy using head-mounted display (HMD)
Number of subjects: 0
Study 21685641 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy using computer automatic virtual environment (CAVE)
Number of subjects: 0
Study 21685641 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 18951454 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation intervention
Number of subjects: 38
Study 18951454 — intervention group
Group type: COMPARATOR
Intervention: Relaxation intervention
Number of subjects: 38
Study 16859143 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-level positive airway pressure ventilation (BiPAP)
Number of subjects: 40
Study 16859143 — intervention group
Group type: COMPARATOR
Intervention: Extubation when awake (Group A)
Number of subjects: 40
Study 15228844 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin-A in combination with methotrexate
Number of subjects: 63
Study 11471481 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care management by pharmacists in the intervention group.
Number of subjects: 1054
Study 11471481 — intervention group
Group type: COMPARATOR
Intervention: Standard care in the control group.
Number of subjects: 1054
Study 9429994 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 50 mg (multiple doses)
Number of subjects: 83
Study 9429994 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 300 mg plus codeine phosphate 30 mg (control)
Number of subjects: 83
Study 8504531 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (2.8 micrograms of sodium selenite per kilogram of body weight per day)
Number of subjects: 27
Study 8504531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 8504531 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 27
Study 3479296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution of 300 mg ofloxacin
Number of subjects: 13
Study 3479296 — intervention group
Group type: COMPARATOR
Intervention: Tablet form of 300 mg ofloxacin
Number of subjects: 13
Study 3479296 — intervention group
Group type: EXPERIMENTAL
Intervention: Both oral solution and tablet form of 300 mg ofloxacin
Number of subjects: 13
Study 31954679 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral and tricuspid valve repair (TMTVR)
Number of subjects: 228
Study 31954679 — intervention group
Group type: COMPARATOR
Intervention: Isolated transcatheter mitral valve repair (TMVR)
Number of subjects: 228
Study 29309282 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound examinations and ultrasound-guided recruitment maneuver
Number of subjects: 120
Study 29309282 — intervention group
Group type: COMPARATOR
Intervention: Lung ultrasound examinations only (control group)
Number of subjects: 120
Study 27451327 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg E4
Number of subjects: 49
Study 27451327 — intervention group
Group type: COMPARATOR
Intervention: 2mg E2V
Number of subjects: 49
Study 27451327 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg E4
Number of subjects: 49
Study 27451327 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg E4
Number of subjects: 49
Study 27451327 — intervention group
Group type: EXPERIMENTAL
Intervention: 40mg E4
Number of subjects: 49
Study 24743712 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/d
Number of subjects: 21
Study 24743712 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600 mg/d
Number of subjects: 21
Study 24743712 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine XR 300 mg/d vs 600 mg/d
Number of subjects: 21
Study 24202220 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid pectin‐based skin barrier
Number of subjects: 0
Study 24202220 — intervention group
Group type: COMPARATOR
Intervention: Gauze
Number of subjects: 0
Study 20453723 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (standard decompressive laminectomy)
Number of subjects: 654
Study 20453723 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 654
Study 18476982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d. as add-on to metformin therapy or as monotherapy
Number of subjects: 0
Study 18476982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d. as monotherapy
Number of subjects: 0
Study 18476982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16669963 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisacodyl, 10 mg once daily
Number of subjects: 55
Study 16669963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 16669963 — intervention group
Group type: COMPARATOR
Intervention: Bisacodyl and Placebo
Number of subjects: 55
Study 15568942 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiration of 100% oxygen for 6 min
Number of subjects: 2
Study 15568942 — intervention group
Group type: COMPARATOR
Intervention: Young healthy subject
Number of subjects: 2
Study 15568942 — intervention group
Group type: COMPARATOR
Intervention: Patient suffering from dry age-related macular degeneration
Number of subjects: 2
Study 11406322 — intervention group
Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 9
Study 11406322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 9008376 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing empathy for a young woman with AIDS
Number of subjects: 3
Study 9008376 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing empathy for a homeless man
Number of subjects: 3
Study 9008376 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducing empathy toward a convicted murderer
Number of subjects: 3
Study 8477272 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulimic subjects
Number of subjects: 24
Study 8477272 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 24
Study 3459738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prophylaxis immediately
Number of subjects: 200
Study 3459738 — intervention group
Group type: COMPARATOR
Intervention: Oral prophylaxis 6 weeks after baseline
Number of subjects: 200
Study 30956141 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-based training (ABT) program, four sessions (4 h/session) over 7 weeks, practice target of 20 min twice-daily
Number of subjects: 0
Study 30956141 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-based training (ABT) program
Number of subjects: 0
Study 30956141 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0
Study 29468642 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 ml ropivacaine
Number of subjects: 20
Study 29468642 — intervention group
Group type: COMPARATOR
Intervention: 8 ml isotonic saline
Number of subjects: 20
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan
Number of subjects: 15244
Study 26511535 — intervention group
Group type: COMPARATOR
Intervention: amlodipine
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP ≥ 90 mmHg
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP < 70 mmHg
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP ≥ 150 mmHg
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP < 130 mmHg
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP strata ≥ 150/90 mmHg
Number of subjects: 15244
Study 26511535 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP strata < 130/70 mmHg
Number of subjects: 15244
Study 23774010 — intervention group
Group type: EXPERIMENTAL
Intervention: Sidman avoidance procedure
Number of subjects: 0
Study 23774010 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant variability procedure
Number of subjects: 0
Study 22854412 — intervention group
Group type: EXPERIMENTAL
Intervention: High-antioxidant diet (5 servings of vegetables and 2 servings of fruit daily; n = 46)
Number of subjects: 137
Study 22854412 — intervention group
Group type: COMPARATOR
Intervention: Low-antioxidant diet (≤2 servings of vegetables and 1 serving of fruit daily; n = 91)
Number of subjects: 137
Study 20616619 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 38
Study 20616619 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 38
Study 20616619 — intervention group
Group type: COMPARATOR
Intervention: Exenatide
Number of subjects: 38
Study 20616619 — intervention group
Group type: COMPARATOR
Intervention: Vildagliptin
Number of subjects: 38
Study 17610650 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved skin of DM patients
Number of subjects: 13
Study 17610650 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-involved skin of DM patients
Number of subjects: 13
Study 17610650 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 13
Study 15919283 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose anticoagulation (target INR range 1.8 to 2.8 for aortic valve replacement and 2.5 to 3.5 for mitral or double valve replacement)
Number of subjects: 1818
Study 15919283 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose anticoagulation (target INR range 2.5 to 4.5 for all heart valve prostheses)
Number of subjects: 1818
Study 12033981 — intervention group
Group type: EXPERIMENTAL
Intervention: PureVision lenses (Bausch & Lomb)
Number of subjects: 30
Study 12033981 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus Night & Day lenses (CIBA Vision)
Number of subjects: 30
Study 12033981 — intervention group
Group type: COMPARATOR
Intervention: Both lenses
Number of subjects: 30
Study 9818597 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined topical-intracameral anesthesia (1% lidocaine)
Number of subjects: 162
Study 9818597 — intervention group
Group type: COMPARATOR
Intervention: Topical lidocaine (2% lidocaine hydrochloride) alone
Number of subjects: 162
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC of sevoflurane
Number of subjects: 36
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 MAC of sevoflurane
Number of subjects: 36
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC of isoflurane
Number of subjects: 36
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 MAC of isoflurane
Number of subjects: 36
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC of halothane
Number of subjects: 36
Study 7696065 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 MAC of halothane
Number of subjects: 36
Study 2796753 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support system using decision tables
Number of subjects: 0
Study 787913 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalexin
Number of subjects: 179
Study 787913 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 179
Study 31599811 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 44
Study 31599811 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 44
Study 31599811 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 44
Study 31599811 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 44
Study 31002578 — intervention group
Group type: COMPARATOR
Intervention: IV carboplatin
Number of subjects: 1560
Study 31002578 — intervention group
Group type: EXPERIMENTAL
Intervention: IP carboplatin
Number of subjects: 1560
Study 31002578 — intervention group
Group type: EXPERIMENTAL
Intervention: IP cisplatin
Number of subjects: 1560
Study 31002578 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 1560
Study 27465823 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthetic alone (Arm A)
Number of subjects: 201
Study 27465823 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetic plus corticosteroid (Arms B and C)
Number of subjects: 201
Study 27465823 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetic plus corticosteroid with a large volume of normal saline (Arm C)
Number of subjects: 201
Study 24849736 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation with 26 vitamins and minerals tablet
Number of subjects: 3318
Study 24849736 — intervention group
Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 3318
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) 300 μg every 2 weeks starting on Day 28 after HCT
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) plus intravenous (i.v.) iron 200 mg on Days 28, 42, and 56
Number of subjects: 72
Study 23873823 — intervention group
Group type: COMPARATOR
Intervention: No darbepoetin alfa (Arm 1)
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) plus intravenous (i.v.) iron
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) administration
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) iron administration
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline hemoglobin
Number of subjects: 72
Study 23873823 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline creatinine
Number of subjects: 72
Study 21726411 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 371
Study 21726411 — intervention group
Group type: COMPARATOR
Intervention: Metformin/Placebo
Number of subjects: 371
Study 21726411 — intervention group
Group type: COMPARATOR
Intervention: Insulin Aspart/NPH Insulin with Metformin/Placebo
Number of subjects: 371
Study 21726411 — intervention group
Group type: COMPARATOR
Intervention: Insulin Aspart/NPH Insulin with Rosiglitazone/Placebo
Number of subjects: 371
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by Kryptor assay
Number of subjects: 56
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by VIDAS assay
Number of subjects: 56
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) at a threshold of 0.5 ng/mL
Number of subjects: 56
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels
Number of subjects: 56
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) thresholds
Number of subjects: 56
Study 19562990 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels in severe sepsis and MOD group
Number of subjects: 56
Study 17206671 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 1 mg/g (1 g ointment twice a day)
Number of subjects: 19
Study 17206671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 17206671 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus
Number of subjects: 19
Study 15502061 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine (ITM) - 250 microg
Number of subjects: 41
Study 15502061 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted femoral nerve block (FNB) - 40 mL of 0.5% ropivacaine, 5 microg/mL of epinephrine, and 75 microg of clonidine
Number of subjects: 41
Study 11392450 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (Taxotere)
Number of subjects: 640
Study 11392450 — intervention group
Group type: EXPERIMENTAL
Intervention: Population PK/PD models
Number of subjects: 640
Study 9785066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous patient-controlled analgesia combined with intercostal blockade (T7-T11) using 0.45% bupivacaine and 0.6% phenol
Number of subjects: 37
Study 9785066 — intervention group
Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia alone
Number of subjects: 37
Study 8162986 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI-204,219 (20 mg)
Number of subjects: 10
Study 8162986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3348735 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein bypass (including in situ and reversed saphenous vein)
Number of subjects: 596
Study 3348735 — intervention group
Group type: COMPARATOR
Intervention: Prosthetic bypass
Number of subjects: 596
Study 3348735 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein bypass
Number of subjects: 596
Study 3348735 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ and reversed saphenous vein bypasses
Number of subjects: 596
Study 31721596 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-session
Number of subjects: 0
Study 31721596 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-free-session
Number of subjects: 0
Study 31721596 — intervention group
Group type: COMPARATOR
Intervention: Stop-session
Number of subjects: 0
Study 31721596 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-session and Nicotine-free-session
Number of subjects: 0
Study 31158295 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated reminiscence
Number of subjects: 13
Study 31158295 — intervention group
Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 13
Study 28646809 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial Distortion Model (FDM) treatment
Number of subjects: 77
Study 28646809 — intervention group
Group type: COMPARATOR
Intervention: NDMG treatment (control)
Number of subjects: 77
Study 25844684 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol
Number of subjects: 720
Study 25844684 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 720
Study 25844684 — intervention group
Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 720
Study 23965206 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (15 mg/kg bolus before incision, followed by 15 mg/kg continuous infusion until skin closure)
Number of subjects: 68
Study 23965206 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 68
Study 23965206 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study 21075773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 704
Study 21075773 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator (ICD) only therapy
Number of subjects: 704
Study 19841361 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pancreas (n = 17)
Number of subjects: 30
Study 19841361 — intervention group
Group type: COMPARATOR
Intervention: Sliding scale method (n = 13)
Number of subjects: 30
Study 16415310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine plus clonidine (Group R)
Number of subjects: 23
Study 16415310 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group S)
Number of subjects: 23
Study 15231441 — intervention group
Group type: EXPERIMENTAL
Intervention: Gulf War veterans with PTSD
Number of subjects: 19
Study 15231441 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy, nondeployed veterans)
Number of subjects: 19
Study 10911769 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet enriched in medium-chain triacylglycerol (TAG)
Number of subjects: 2
Study 10911769 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized lipid-enriched test meal
Number of subjects: 2
Study 9118189 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.77% KAl(SO4) toothpaste
Number of subjects: 2087
Study 9118189 — intervention group
Group type: COMPARATOR
Intervention: 0.83% NaFPO3 toothpaste
Number of subjects: 2087
Study 8440429 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave coagulation (non-contact method)
Number of subjects: 40
Study 8440429 — intervention group
Group type: COMPARATOR
Intervention: Polidocanol 1% + adrenaline 1:10,000 injection
Number of subjects: 40
Study 3734514 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (200 mg t.i.d.)
Number of subjects: 39